𝔖 Bobbio Scriptorium
✦   LIBER   ✦

TOXICITY PREVENTION WITH AMIFOSTINE IN PEDIATRIC OSTEOSARCOMA PATIENTS TREATED WITH CISPLATIN AND DOXORUBICIN

✍ Scribed by Gallegos-Castorena, Sergio; Martínez-Avalos, Armando; Mohar-Betancourt, Alejandro; Guerrero-Avendaño, Guadalupe; Zapata-Tarrés, Martha; Medina-Sansón, Aurora

Book ID
125833617
Publisher
Informa plc
Year
2007
Tongue
English
Weight
63 KB
Volume
24
Category
Article
ISSN
0888-0018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Retinal toxicity associated with cisplat
Retinal toxicity associated with cisplatin and etoposide in pediatric patients
✍ Hilliard, Lee M.; Berkow, Roger L.; Watterson, Jan; Ballard, Evan A.; Balzer, Ge 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB 👁 2 views

Cisplatin is an effective chemotherapeutic agent used in the treatment of many pediatric solid tumors. Retinal toxicity is a side effect of the drug reported in adults, but is not well described in pediatric patients. We present the cases of two children treated with cisplatin and etoposide who expe

Systemic doxorubicin and intraarterial c
Systemic doxorubicin and intraarterial cisplatin preoperative chemotherapy plus postoperative adjuvant chemotherapy in patients with osteosarcoma
✍ Kimo C. Stine; Marilyn J. Hockenberry; John Harrelson; Dan Miner; John M. Fallet 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 592 KB

The role of adjuvant chemotherapy for osteosarcoma has been well defined. Recently, the use of preoperative chemotherapy has been further enhanced by the use of intraarterial cisplatin. The authors describe the use and results of systemic doxorubicin and intraarterial cisplatin as a preoperative reg